Yew Bio Pharm Group Inc Revenue Growth Rates (YEWB), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Yew Bio pharm Group Inc   (YEWB)
 

YEWB's Revenue Growth by Quarter and Year

Yew Bio Pharm Group Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

YEWB Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September 0.11
2nd Quarter June 14.84
1st Quarter March 8.74
FY 23.69

YEWBs Annual Revenue
Yew Bio Pharm Group Inc 's Revenue in the fiscal year 2020 $ 27.31 millions
Yew Bio Pharm Group Inc 's Revenue in the fiscal year 2019 $ 27.88 millions
Yew Bio Pharm Group Inc 's Revenue in the fiscal year 2018 $ 37.60 millions
Yew Bio Pharm Group Inc 's Revenue in the fiscal year 2017 $ 40.54 millions
Yew Bio Pharm Group Inc 's Revenue in the fiscal year 2016 $ 51.35 millions




YEWB Revenue third quarter 2021 Y/Y Growth Comment
Yew Bio Pharm Group Inc reported drop in Revenue in the third quarter 2021 by -98.94% to $ 0.11 millions, from the same quarter in 2020.
This represents worst decline in recent Company history.

Looking into third quarter 2021 results within Agricultural Production industry 35 other companies have achieved higher Revenue growth. While Yew Bio Pharm Group Inc ' s Revenue meltdown of -98.94% ranks overall at the positon no. 3743 in the third quarter 2021.


YEWB Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December - 70.7 % -45.01 % 4.01 %
3rd Quarter September -98.94 % 1446.27 % -95.23 % 21.45 %
2nd Quarter June 55.23 % -23.95 % -15.18 % -5 %
1st Quarter March 330.54 % -82.36 % 279.87 % -61.55 %
FY   - -2.08 % -25.82 % -

Financial Statements
Yew Bio Pharm Group Inc 's third quarter 2021 Revenue $ 0.11 millions YEWB's Income Statement
Yew Bio Pharm Group Inc 's third quarter 2020 Revenue $ 10.36 millions Quarterly YEWB's Income Statement


YEWB Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - -48.26 % 368.66 % -59.33 %
3rd Quarter September -99.26 % 8.37 % -94.67 % -5.26 %
2nd Quarter June 69.79 % 370.94 % 9.21 % 389.11 %
1st Quarter March 63.06 % -35.35 % 101.58 % -44.81 %
FY (Year on Year)   - -2.08 % -25.82 % -


Back to YEWB Growth rate Comparisons >> Back to YEWB Growth rate Comparisons >>


Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #36
Consumer Non Cyclical Sector #161
Overall #3743

Revenue Y/Y Growth Statistics
High Average Low
1451.28 % 103.69 % -98.94 %
(Sep 30 2020)   (Sep 30 2021)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #36
Consumer Non Cyclical Sector #161
Overall #3743
Revenue Y/Y Growth Statistics
High Average Low
1451.28 % 103.69 % -98.94 %
(Sep 30 2020)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Yew Bio Pharm Group Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
388.94 % 52.74 % -99.26 %
(Jun 30 2018)  


YEWB's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Yew Bio Pharm Group Inc disclosed fall in Revenue from the second quarter by -99.26% to $ 0.11 millions, from $ 14.84 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2021 Revenue, this plainly could not be substantial to rescue Agricultural Production's company achievement, Most analysts pointed out.

Within Agricultural Production industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Yew Bio Pharm Group Inc 's Revenue growth quarter on quarter, overall rank is 4176.


Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #20
Consumer Non Cyclical Sector #155
Overall #4176
Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #20
Consumer Non Cyclical Sector #155
Overall #4176
Revenue Q/Q Growth Statistics
High Average Low
388.94 % 52.74 % -99.26 %
(Jun 30 2018)  


YEWB's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Yew Bio Pharm Group Inc disclosed fall in Revenue from the second quarter by -99.26% to $ 0.11 millions, from $ 14.84 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2021 Revenue, this plainly could not be substantial to rescue Agricultural Production's company achievement, Most analysts pointed out.

Within Agricultural Production industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Yew Bio Pharm Group Inc 's Revenue growth quarter on quarter, overall rank is 4176.


Yew Bio Pharm Group Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 29.05 $ 39.30 $ 34.02 $ 27.31 $ 25.08
Y / Y Revenue Growth (TTM) 15.82 % 155.25 % 84.88 % -2.07 % -17.63 %
Year on Year Revenue Growth Overall Ranking # 3197 # 190 # 213 # 1779 # 2446
Seqeuential Revenue Change (TTM) -26.07 % 15.53 % 24.56 % 8.87 % 62.92 %
Seq. Revenue Growth (TTM) Overall Ranking # 3588 # 676 # 215 # 641 # 70


Cumulative Revenue growth Comment
Assuming the Yew Bio Pharm Group Inc 's fiscal year would have ended in Sep 30 2021, Yew Bio Pharm Group Inc would have reprted above average annual Revenue increase of 15.82% year on year, of $ 29 millions.
This marks a slow-down of the companys growth trends and from the 155.25% surge in Jun 30 2021.

In the Consumer Non Cyclical sector 141 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 190 to 3197.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 17
Consumer Non Cyclical Sector # 142
Overall # 3197

Revenue TTM Y/Y Growth Statistics
High Average Low
155.25 %
 8.53 %
-64.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 140
S&P 500 # 3588
Cumulative Revenue growth Comment
Assuming the Yew Bio Pharm Group Inc 's fiscal year would have ended in Sep 30 2021, Yew Bio Pharm Group Inc would have reprted above average annual Revenue increase of 15.82% year on year, of $ 29 millions.
This marks a slow-down of the companys growth trends and from the 155.25% surge in Jun 30 2021.

In the Consumer Non Cyclical sector 141 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 190 to 3197.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 17
Consumer Non Cyclical Sector # 142
Overall # 3197

Revenue TTM Y/Y Growth Statistics
High Average Low
155.25 %
8.53 %
-64.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 140
S&P 500 # 3588




Other Revenue Growth
Agricultural Production Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
YEWB's Revenue Growth Ratio versus Agricultural Production Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Sep 30 2021 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Twinlab Consolidated Holdings Inc -0.54%$ -0.539 millions
Kraft Heinz Co-1.82%$ -1.816 millions
Diversey Holdings Ltd -2.38%$ -2.379 millions
Fitlife Brands Inc -3.15%$ -3.149 millions
Canopy Growth Corporation-3.43%$ -3.434 millions
Healthier Choices Management Corp -3.44%$ -3.439 millions
Natural Alternatives International Inc-3.49%$ -3.489 millions
Brewbilt Brewing Company-5.54%$ -5.538 millions
The Clorox Company-5.74%$ -5.741 millions
Blue Star Foods Corp -6.37%$ -6.369 millions
Agrofresh Solutions inc -6.81%$ -6.807 millions
Eos Inc -6.95%$ -6.954 millions
The Hain Celestial Group Inc -8.77%$ -8.769 millions
Nightfood Holdings Inc -9.87%$ -9.867 millions
China Green Agriculture Inc-15.35%$ -15.348 millions
Healthy Extracts Inc -15.97%$ -15.966 millions
Equator Beverage Company-16.70%$ -16.696 millions
Scotts Miracle gro Co-17.34%$ -17.343 millions
Alico Inc -17.78%$ -17.780 millions
Bloomia Holdings inc -22.22%$ -22.222 millions
Avon Products Inc -23.02%$ -23.016 millions
Beeline Holdings Inc -29.68%$ -29.683 millions
Altria Group Inc -30.82%$ -30.816 millions
Vector Group Ltd-45.52%$ -45.515 millions
Alpha Network Alliance Ventures Inc -50.84%$ -50.837 millions
Nutralife Biosciences Inc.-54.05%$ -54.050 millions
Yield10 Bioscience inc -54.90%$ -54.902 millions
Panacea Life Sciences Holdings Inc -56.23%$ -56.234 millions
Veritas Farms Inc -62.10%$ -62.104 millions
Quanta Inc.-67.59%$ -67.590 millions


About Yew Bio Pharm Group Inc Revenue Growth Rates (YEWB), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.